Download Full Volume - United States Renal Data System

More documents

Recommendations

Info

AINCIDENCE OF REPORTED ESRD Reference section A Table A.9 A.9 (continued) Incident rates of of reported ESRD, by by diabetic status & state, adjusted: non-diabetic patients per per million million population population 312 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 Alabama 145.9 155.0 158.1 165.9 169.4 177.2 169.5 173.2 171.8 176.3 173.4 Alaska 81.2 255.2 477.9 121.6 101.8 81.1 99.4 122.5 105.2 106.5 145.8 Arizona 168.1 151.0 149.6 167.6 155.0 173.2 174.7 172.1 180.0 162.9 186.7 Arkansas 145.0 174.0 175.0 156.6 186.0 158.6 176.5 163.5 172.4 179.1 172.1 California 165.9 179.6 171.8 176.0 174.5 190.0 192.3 189.4 196.6 205.7 204.1 Colorado 113.9 129.3 101.3 112.4 133.0 132.2 126.5 126.7 120.7 121.7 122.4 Connecticut 158.8 170.2 160.9 172.4 148.3 170.4 166.4 169.6 165.8 160.2 141.4 Delaware 156.5 182.5 199.8 179.9 168.8 171.0 173.6 184.1 177.8 198.3 204.8 District of Columbia 176.8 166.5 171.9 132.3 154.3 155.7 199.1 214.9 146.2 155.5 176.1 Florida 171.2 172.5 164.7 176.3 171.9 173.5 176.3 175.1 176.5 183.3 175.6 Georgia 162.2 170.2 168.8 167.5 161.4 174.1 186.7 190.1 190.5 189.0 189.9 Hawaii 80.0 107.0 103.5 109.0 142.7 91.9 168.6 123.8 89.5 100.3 82.6 Idaho 143.5 424.6 271.6 140.6 283.9 136.8 301.9 122.0 230.8 175.8 162.3 Illinois 177.6 184.5 182.2 196.1 193.2 202.4 202.8 203.8 208.7 226.9 215.0 Indiana 166.3 158.1 154.0 169.5 175.2 187.4 186.3 201.0 197.3 202.4 192.6 Iowa 157.4 159.7 131.9 190.7 136.8 155.9 194.9 174.1 162.2 199.4 172.5 Kansas 127.0 138.3 142.0 163.8 171.3 156.7 160.9 151.4 153.8 167.5 175.4 Kentucky 148.9 162.0 156.1 158.5 168.0 179.0 182.3 183.0 181.9 179.0 185.0 Louisiana 179.7 187.2 180.8 167.1 193.0 195.5 215.0 211.7 215.9 235.7 239.0 Maine 219.3 127.5 222.8 224.5 112.4 132.0 221.6 104.0 109.3 166.1 147.8 Maryland 153.3 158.7 174.8 170.6 175.7 191.0 196.6 204.6 195.9 194.0 208.6 Massachusetts 166.1 159.2 156.2 165.8 170.0 166.8 164.7 173.5 147.4 168.5 172.8 Michigan 156.2 156.5 154.9 165.1 163.7 173.3 180.2 182.1 183.1 195.3 190.9 Minnesota 141.9 167.8 168.4 167.2 162.9 176.3 176.9 169.1 190.3 180.8 184.6 Mississippi 158.5 163.2 145.5 157.3 171.1 162.1 179.5 172.6 182.7 185.6 180.8 Missouri 169.1 173.2 163.8 163.8 165.0 185.6 190.5 188.9 197.0 177.8 191.1 Montana 133.3 181.2 284.6 91.0 74.7 143.9 96.6 81.1 212.8 78.3 122.4 Nebraska 140.3 167.1 110.4 162.0 154.3 181.4 174.9 175.1 206.3 201.2 185.1 Nevada 176.8 212.5 149.4 164.3 144.8 150.9 183.9 163.2 177.4 166.9 192.2 New Hampshire 90.5 230.5 97.0 120.1 149.0 140.0 154.9 188.7 286.9 192.9 237.9 New Jersey 183.1 189.3 184.8 180.6 194.7 194.5 212.1 198.4 208.8 207.1 212.6 New Mexico 113.5 136.3 126.4 133.9 143.5 125.1 130.7 133.3 130.4 146.7 158.4 New York 164.5 163.1 156.0 162.1 171.7 176.5 178.6 180.5 176.6 179.5 179.7 North Carolina 150.0 154.8 146.1 157.2 169.0 167.8 167.7 179.0 179.6 183.8 175.3 North Dakota 270.4 394.0 268.4 117.3 106.6 98.5 127.5 127.4 135.3 204.8 121.2 Ohio 144.2 154.4 154.0 173.5 164.4 177.0 190.0 194.6 188.7 200.0 207.3 Oklahoma 138.6 143.2 129.8 143.6 161.9 157.7 158.0 157.3 171.6 170.3 195.9 Oregon 150.4 148.6 136.3 140.0 121.4 209.6 154.6 161.0 158.0 204.1 184.9 Pennsylvania 160.6 176.1 168.2 183.7 190.9 188.2 200.4 198.1 184.1 203.3 187.1 Rhode Island 171.9 204.3 162.2 179.6 175.6 169.8 193.4 210.1 185.1 185.7 206.0 South Carolina 155.7 171.5 155.5 156.5 174.2 160.9 172.2 163.3 173.6 166.5 168.1 South Dakota 105.9 118.8 128.8 183.0 360.6 150.3 107.0 181.5 144.4 147.9 239.4 Tennessee 151.9 171.4 166.7 164.3 177.3 189.2 195.1 181.5 171.3 189.4 174.0 Texas 159.6 168.3 154.7 163.1 161.5 175.3 183.6 174.8 180.1 179.3 182.8 Utah 124.9 124.2 103.9 148.2 95.8 104.6 126.0 112.9 106.0 141.4 107.9 Vermont 74.4 98.7 94.9 211.1 400.6 221.0 123.3 103.9 223.3 141.2 248.0 Virginia 156.5 155.4 166.7 173.9 180.2 175.5 185.3 162.3 167.3 183.7 184.1 Washington 125.0 143.6 132.8 140.3 133.6 141.8 146.5 161.7 143.9 172.8 159.7 West Virginia 157.2 194.4 163.7 171.4 196.6 230.9 170.4 178.5 199.7 195.6 176.7 Wisconsin 151.7 160.4 158.0 161.1 159.1 185.6 175.3 186.2 192.4 204.4 209.7 Wyoming 169.7 50.6 119.7 159.3 76.1 94.0 168.9 129.9 131.2 76.2 79.8 All 159.6 167.4 161.3 167.8 171.5 177.8 183.6 182.1 183.2 189.8 189.2 Rates are adjusted by age, gender, & race. The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.
ON OUR WEBSITE & CD Incident counts of reported ESRD patients: U.S. only, with unknowns dropped (A.10.1). INCIDENCE OF REPORTED ESRD 2005 Annual <strong>Data</strong> ReportA Table A.10 A.10 Incident counts of reported ESRD patients, by diabetic status & ESRD network ALL 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1 CT, MA, ME, NH, RI, VT 827 842 1,003 1,255 1,271 1,421 1,429 1,565 1,726 1,925 2,080 2,350 2,494 2 NY 1,479 1,629 1,810 2,096 2,279 2,430 2,734 2,858 3,199 3,428 3,906 4,034 4,558 3 NJ, PR, VI 1,123 1,126 1,293 1,437 1,455 1,701 1,753 1,868 2,040 2,341 2,468 2,721 2,996 4 DE, PA 990 1,072 1,229 1,374 1,563 1,810 1,887 1,961 2,205 2,439 2,853 2,987 3,241 5 MD, DC, VA, WV 1,054 1,160 1,369 1,558 1,662 1,759 1,802 2,130 2,323 2,644 2,868 3,432 3,710 6 NC, SC, GA 1,259 1,497 1,606 1,898 1,974 2,262 2,453 2,765 3,248 3,595 3,878 4,470 4,914 7 FL 1,172 1,246 1,319 1,480 1,671 1,814 2,116 2,414 2,587 2,949 3,101 3,509 3,874 8 AL, MS, TN 883 924 1,059 1,402 1,306 1,459 1,542 1,842 2,030 2,761 2,674 2,909 3,241 9 IN, KY, OH 1,282 1,468 1,674 1,896 1,977 2,237 2,371 2,657 3,040 3,270 3,922 4,185 4,612 10 IL 830 974 1,119 1,275 1,313 1,521 1,617 1,734 1,788 1,982 2,302 2,722 2,763 11 MI, MN, ND, SD, WI 1,414 1,540 1,715 1,748 2,093 2,181 2,370 2,692 2,963 3,316 3,480 3,823 4,266 12 IA, KS, MO, NE 721 805 946 1,008 1,112 1,242 1,386 1,503 1,655 1,865 2,091 2,247 2,506 13 AR, LA, OK 669 787 847 979 1,121 1,184 1,358 1,562 1,928 1,981 2,122 2,342 2,631 14 TX 1,078 1,277 1,525 1,754 1,714 1,964 2,189 2,444 2,794 3,201 3,595 3,937 4,444 15 AZ, CO, NV, NM, UT, WY 775 832 903 1,009 1,123 1,213 1,426 1,578 1,718 1,882 1,946 2,209 2,506 16 AK, ID, MT, OR, WA 459 509 576 699 742 814 943 1,001 1,092 1,349 1,397 1,581 1,573 17 N. CA, HI, Guam, AS 871 885 1,001 1,197 1,298 1,429 1,599 1,776 2,100 2,263 2,631 2,772 2,822 18 S. CA 1,124 1,525 1,584 1,862 1,895 2,153 2,476 2,579 2,821 3,242 3,595 3,929 4,140 Unknown * * * * 12 * 20 22 35 29 17 14 27 313 All 18,017 20,102 22,587 25,935 27,581 30,604 33,471 36,951 41,292 46,462 50,926 56,173 61,318 DIABETIC 1 CT, MA, ME, NH, RI, VT 119 187 219 251 296 356 368 428 463 594 673 785 849 2 NY 202 316 392 489 598 629 798 855 997 1,041 1,263 1,367 1,519 3 NJ, PR, VI 170 223 309 373 421 492 565 603 709 826 960 1,069 1,150 4 DE, PA 181 204 274 316 448 473 547 598 698 801 969 1,095 1,195 5 MD, DC, VA, WV 126 195 294 374 426 478 521 592 665 816 956 1,158 1,341 6 NC, SC, GA 161 258 359 391 495 631 667 860 915 1,126 1,317 1,538 1,740 7 FL 129 205 268 298 369 427 585 656 684 811 929 1,049 1,203 8 AL, MS, TN 85 126 183 239 301 329 377 492 552 802 879 986 1,151 9 IN, KY, OH 225 332 389 494 569 646 707 883 984 1,105 1,416 1,566 1,793 10 IL 139 192 255 294 335 447 463 517 522 622 763 923 904 11 MI, MN, ND, SD, WI 345 411 478 533 659 677 822 895 1,016 1,225 1,353 1,527 1,691 12 IA, KS, MO, NE 86 189 256 259 303 368 390 421 512 601 677 796 906 13 AR, LA, OK 65 126 174 210 288 306 402 476 627 683 750 917 1,042 14 TX 158 268 402 423 547 642 704 827 1,024 1,341 1,541 1,683 1,885 15 AZ, CO, NV, NM, UT, WY 184 220 277 343 409 440 582 683 735 840 854 1,048 1,164 16 AK, ID, MT, OR, WA 80 90 141 167 198 249 264 304 386 483 502 573 639 17 N. CA, HI, Guam, AS 89 189 232 263 300 434 490 591 684 868 1,006 1,065 1,144 18 S. CA 146 312 406 500 549 683 839 795 899 1,184 1,329 1,573 1,649 Unknown . . . * * * * * . * * * * All 2,690 4,043 5,308 6,218 7,513 8,708 10,092 11,477 13,072 15,770 18,138 20,720 22,971 NON-DIABETIC 1 CT, MA, ME, NH, RI, VT 708 655 784 1,004 975 1,065 1,061 1,137 1,263 1,331 1,407 1,565 1,645 2 NY 1,277 1,313 1,418 1,607 1,681 1,801 1,936 2,003 2,202 2,387 2,643 2,667 3,039 3 NJ, PR, VI 953 903 984 1,064 1,034 1,209 1,188 1,265 1,331 1,515 1,508 1,652 1,846 4 DE, PA 809 868 955 1,058 1,115 1,337 1,340 1,363 1,507 1,638 1,884 1,892 2,046 5 MD, DC, VA, WV 928 965 1,075 1,184 1,236 1,281 1,281 1,538 1,658 1,828 1,912 2,274 2,369 6 NC, SC, GA 1,098 1,239 1,247 1,507 1,479 1,631 1,786 1,905 2,333 2,469 2,561 2,932 3,174 7 FL 1,043 1,041 1,051 1,182 1,302 1,387 1,531 1,758 1,903 2,138 2,172 2,460 2,671 8 AL, MS, TN 798 798 876 1,163 1,005 1,130 1,165 1,350 1,478 1,959 1,795 1,923 2,090 9 IN, KY, OH 1,057 1,136 1,285 1,402 1,408 1,591 1,664 1,774 2,056 2,165 2,506 2,619 2,819 10 IL 691 782 864 981 978 1,074 1,154 1,217 1,266 1,360 1,539 1,799 1,859 11 MI, MN, ND, SD, WI 1,069 1,129 1,237 1,215 1,434 1,504 1,548 1,797 1,947 2,091 2,127 2,296 2,575 12 IA, KS, MO, NE 635 616 690 749 809 874 996 1,082 1,143 1,264 1,414 1,451 1,600 13 AR, LA, OK 604 661 673 769 833 878 956 1,086 1,301 1,298 1,372 1,425 1,589 14 TX 920 1,009 1,123 1,331 1,167 1,322 1,485 1,617 1,770 1,860 2,054 2,254 2,559 15 AZ, CO, NV, NM, UT, WY 591 612 626 666 714 773 844 895 983 1,042 1,092 1,161 1,342 16 AK, ID, MT, OR, WA 379 419 435 532 544 565 679 697 706 866 895 1,008 934 17 N. CA, HI, Guam, AS 782 696 769 934 998 995 1,109 1,185 1,416 1,395 1,625 1,707 1,678 18 S. CA 978 1,213 1,178 1,362 1,346 1,470 1,637 1,784 1,922 2,058 2,266 2,356 2,491 Unknown * * * * * * 19 21 35 28 16 12 21 All 15,327 16,059 17,279 19,717 20,068 21,896 23,379 25,474 28,220 30,692 32,788 35,453 38,347 The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. *Values for cells with 10 or fewer patients are suppressed. "." Zero values in this cell.
Page 1 and 2: Reference A Section Incidence of re
Page 3 and 4: ON OUR WEBSITE & CD Incident counts
Page 5 and 6: INCIDENCE OF REPORTED ESRD 2005 Ann
Page 7 and 8: ON OUR WEBSITE & CD Incident rates
Page 15 and 16: ON OUR WEBSITE & CD Median age at s
Page 17 and 18: ON OUR WEBSITE & CD Incidence of re
Page 21 and 22: Table A.8 A.8 (continued) Incident
Page 29: Table A.9 A.9 (continued) Incident
Page 35 and 36: Reference B Section Prevalence of r
Page 37 and 38: ON OUR WEBSITE & CD Point prevalent
Page 39 and 40: Table B.1 B.1 (continued) Point pre
Page 45 and 46: PREVALENCE OF REPORTED ESRD 2005 An
Page 49 and 50: ON OUR WEBSITE & CD Median age at s
Page 51 and 52: ON OUR WEBSITE & CD Prevalence of r
Page 55 and 56: Table B.8 B.8 (continued) PREVALENC
Page 57 and 58: Table B.8 B.8 (continued) PREVALENC
Page 59 and 60: Table B.9 B.9 Point prevalent rates
Page 67 and 68: Table B.11 B.11 Point prevalent rat
Page 69 and 70: PREVALENCE OF REPORTED ESRD 2005 An
Page 71 and 72: Reference C Section Patient charact
Page 73 and 74: PATIENT CHARACTERISTICS 2005 Annual
Page 81 and 82:
PATIENT CHARACTERISTICS 2005 Annual
Page 83 and 84:
ON OUR WEBSITE & CD Mean eGFR by MD
Page 85 and 86:
Table C.14 C.14 Percent distributio
Page 87 and 88:
Reference D Section Treatment modal
Page 89 and 90:
TREATMENT MODALITIES 2005 Annual Da
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
ON OUR WEBSITE & CD Incident ESRD p
Page 109 and 110:
ON OUR WEBSITE & CD Treatment statu
Page 111 and 112:
Page 113 and 114:
ON OUR WEBSITE & CD Living ESRD pat
Page 115 and 116:
Reference E Section Transplantation
Page 117 and 118:
TRANSPLANTATION: 2005 Annual Data P
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
ON OUR WEBSITE & CD Median time in
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
ON OUR WEBSITE & CD Renal transplan
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Reference F Section Transplantation
Page 141 and 142:
ON OUR WEBSITE & CD 90-day death-ce
Page 143 and 144:
ON OUR WEBSITE & CD One-year death-
Page 145 and 146:
ON OUR WEBSITE & CD Two-year death-
Page 147 and 148:
ON OUR WEBSITE & CD Three-year deat
Page 149 and 150:
ON OUR WEBSITE & CD Five-year death
Page 151 and 152:
ON OUR WEBSITE & CD Ten-year graft
Page 153 and 154:
TRANSPLANTATION: 2005 Annual OUTCOM
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Table F.13 F.13 90-day survival wit
Page 165 and 166:
Table Table F.14 F.14 One-year surv
Page 167 and 168:
Page 169 and 170:
Table F.16 F.16 Three-year survival
Page 171 and 172:
Table Table F.17 F.17 Five-year sur
Page 173 and 174:
Table F.18 F.18 Ten-year survival w
Page 175 and 176:
Page 177 and 178:
Table F.20 F.20 (continued) One-yea
Page 179 and 180:
Table F.21 F.21 (continued) Two-yea
Page 181 and 182:
Table Table F.22 F.22 (continued) (
Page 183 and 184:
Table F.23 F.23 (continued) Five-ye
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Reference G Section Morbidity & hos
Page 195 and 196:
ON OUR WEBSITE & CD jkfj Total admi
Page 197 and 198:
ON OUR WEBSITE & CD Total admission
Page 199 and 200:
ON OUR WEBSITE & CD Total admission
Page 201 and 202:
ON OUR WEBSITE & CD Hospital days p
Page 203 and 204:
ON OUR WEBSITE & CD Hospital days p
Page 205 and 206:
Table G.11 G.11 Inpatient utilizati
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
MORBIDITY & 2005 HOSPITALIZATIONG A
Page 213 and 214:
MORBIDITY & 2005 HOSPITALIZATIONG A
Page 215 and 216:
Reference H Section Mortality & cau
Page 217 and 218:
MORTALITY & CAUSES OF DEATH 2005 An
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Table H.6 H.6 (continued) Annual mo
Page 233 and 234:
Page 235 and 236:
Table H.8 H.8 (continued) Annual mo
Page 237 and 238:
Page 239 and 240:
Table H.10 H.10 (continued) Annual
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Table H.16 H.16 Annual mortality ra
Page 251 and 252:
Table H.17 H.17 (continued) Total p
Page 253 and 254:
Table H.18 H.18 (continued) MORTALI
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Table H.24 H.24 Annual mortality ra
Page 265 and 266:
Page 267 and 268:
Table H.26 H.26 (continued) MORTALI
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
ON OUR WEBSITE & CD Mortality rates
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Reference I Section Patient surviva
Page 295 and 296:
I PATIENT SURVIVAL 2005 Annual Data
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Table I.8 (continued) Table Inciden
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Reference J Section Provider charac
Page 373 and 374:
Table J.1 J.1 Certified dialysis &
Page 375 and 376:
Table J.5 J.5 Dialysis & transplant
Page 377 and 378:
PROVIDER CHARACTERISTICS 2005 Annua
Page 379 and 380:
Table J.13 J.13 Dialysis patients:
Page 381 and 382:
PROVIDER CHARACTERISTICS JReference
Page 383 and 384:
Reference K Section Medicare costs
Page 385 and 386:
Table K.1 K.1 Total Medicare costs
Page 387 and 388:
MEDICARE COSTS FOR ESRD 2005 Annual
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Reference L Section Vascular access
Page 403 and 404:
Table L.1 L.1 Catheter insertions i
Page 405 and 406:
Table L.3 L.3 Graft insertions in p
Page 407 and 408:
VASCULAR 2005 Annual Data ACCESSL R
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Table L.12 L.12 Arteriovenous fistu
Page 423 and 424:
Reference M Section Census populati
Page 425 and 426:
CENSUS POPULATIONS 2005 Annual Data
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Table M.2 M.2 Resident population e
show all

Download Full Volume - United States Renal Data System

Create successful ePaper yourself

Delete template?

Save as template?